Trial Profile
CONIFER (Characterization of NSAID Intake for Established Rheumatoid Arthritis)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 15 Dec 2018
Price :
$35
*
At a glance
- Drugs Tocilizumab (Primary) ; Tocilizumab (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Acronyms CONIFER
- Sponsors Roche
- 22 Oct 2018 Status changed from active, no longer recruiting to completed.
- 10 Jan 2018 Status changed from recruiting to active, no longer recruiting.
- 18 Apr 2017 New trial record